Brain Tumour Radiotherapy & SRS
Sub-millimeter Stereotactic Radiosurgery (SRS) and fractionated radiotherapy for primary brain tumors and intracranial metastases.
Sub-millimeter targeting that protects cognitive function, memory pathways, and optic nerves.
Modern neuro-oncology radiation requires extraordinary spatial accuracy. Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) deliver high ablative doses in 1 to 5 non-invasive sessions without incisions or invasive skull pins.
Planning integrates high-resolution diagnostic 3T MRI with thin-slice planning CT, ensuring precise tumor boundary definition and maximum sparing of critical neuro-cognitive structures including the hippocampi, optic chiasm, and brainstem.
We manage both primary CNS malignancies (Glioblastoma, Astrocytoma, Meningioma, Ependymoma) and brain metastases, providing targeted treatment that avoids whole-brain cognitive side effects whenever possible.
Key Clinical Considerations in Your Consultation
Every recommendation is customized according to staging scans, pathology markers, and patient priorities.
Frameless Stereotactic Radiosurgery (SRS) for single and multiple brain metastases
Fractionated stereotactic radiotherapy (SRT) for skull base meningiomas & acoustic neuromas
Postoperative adjuvant radiotherapy with concurrent Temozolomide for high-grade gliomas
Hippocampal-sparing radiotherapy to preserve neurocognitive and memory function
Re-irradiation assessment for recurrent brain lesions
Multidisciplinary review with neurosurgeons and neuropathologists
Discuss Brain Tumour Radiotherapy & SRS
Bring biopsy reports, recent PET/CT or MRI scans, and operative summaries for a comprehensive consultation.